Plus Therapeutics (NASDAQ:PSTV) PT Lowered to $20.00

Plus Therapeutics (NASDAQ:PSTV – Free Report) had its price target lowered by Ascendiant Capital Markets from $21.00 to $20.00 in a research note published on Tuesday, Benzinga reports. The brokerage currently has a buy rating on the stock. Separately, HC Wainwright restated a buy rating and issued a $8.00 price target on shares of Plus […]